Variant report
Variant | esv3454842 |
---|---|
Chromosome Location | chr11:93019304-93024102 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs575144500 | chr11:93019307-93019308 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs4575225 | chr11:93019466-93019467 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs11020242 | chr11:93019552-93019553 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs542912895 | chr11:93019676-93019677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs7483680 | chr11:93019731-93019732 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs375141813 | chr11:93019754-93019755 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs78870262 | chr11:93019795-93019796 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs550326867 | chr11:93019832-93019833 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs143559945 | chr11:93019833-93019834 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs185644607 | chr11:93019837-93019838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs113413663 | chr11:93019891-93019892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs12807018 | chr11:93019901-93019902 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs191531661 | chr11:93019903-93019904 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs182558138 | chr11:93019905-93019906 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs12226442 | chr11:93019924-93019925 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs570507651 | chr11:93019929-93019930 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs537681370 | chr11:93019932-93019933 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs112219507 | chr11:93019941-93019942 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs527518716 | chr11:93019946-93019947 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs369721824 | chr11:93019947-93019948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs574687869 | chr11:93019953-93019954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs553703870 | chr11:93019960-93019961 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs554064591 | chr11:93019991-93019992 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs193018512 | chr11:93020021-93020022 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs370148373 | chr11:93020054-93020055 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs542002538 | chr11:93020059-93020060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs183238264 | chr11:93020094-93020095 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs564449705 | chr11:93020113-93020114 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs576464723 | chr11:93020143-93020144 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs562084148 | chr11:93020168-93020169 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs562311582 | chr11:93020227-93020228 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs147350159 | chr11:93020272-93020273 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs531232014 | chr11:93020273-93020274 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs187271005 | chr11:93020275-93020276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs543051661 | chr11:93020321-93020322 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs559592137 | chr11:93020335-93020336 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs192146794 | chr11:93020355-93020356 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs551741600 | chr11:93020443-93020444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs148809519 | chr11:93020459-93020460 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs11020243 | chr11:93020483-93020484 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
41 | rs549563399 | chr11:93020499-93020500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs10765599 | chr11:93020527-93020528 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs561142330 | chr11:93020540-93020541 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs531594169 | chr11:93020549-93020550 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs377310240 | chr11:93020590-93020591 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs117745543 | chr11:93020600-93020601 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs374350194 | chr11:93020645-93020646 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs368570451 | chr11:93020668-93020669 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs565197348 | chr11:93020679-93020680 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs572348566 | chr11:93020705-93020706 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Developmental delay | 21147756 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Mental retardation | 21062444 | CNVD |
Cancer | 21499728 | CNVD |
Breast cancer | 19181860 | CNVD |
Breast cancer | 17603634 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Breast cancer | 21509527 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:93016600-93020600 | Weak transcription | GM12878-XiMat | blood |
2 | chr11:93018800-93020600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr11:93018800-93021400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr11:93019000-93019600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr11:93019400-93028600 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
6 | chr11:93020600-93021200 | Enhancers | GM12878-XiMat | blood |
7 | chr11:93020600-93021600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
8 | chr11:93021200-93021800 | Flanking Active TSS | GM12878-XiMat | blood |
9 | chr11:93021400-93021600 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
10 | chr11:93021400-93021600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
11 | chr11:93021600-93024400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
12 | chr11:93021800-93023400 | Enhancers | GM12878-XiMat | blood |
13 | chr11:93022200-93022800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr11:93022800-93023600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
15 | chr11:93023000-93023200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
16 | chr11:93023200-93028600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
17 | chr11:93023400-93025200 | Weak transcription | GM12878-XiMat | blood |
18 | chr11:93023400-93025600 | Bivalent Enhancer | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |